Literature DB >> 34826020

Cardiovascular risk reclassification according to six cardiovascular risk algorithms and carotid ultrasound in psoriatic arthritis patients.

Dionicio A Galarza-Delgado1, Jose R Azpiri-Lopez2, Iris J Colunga-Pedraza1, Natalia Guajardo-Jauregui1, Alejandra B Rodriguez-Romero1, Salvador Lugo-Perez3, Jesus A Cardenas-de la Garza1, Rosa I Arvizu-Rivera1, Diana E Flores-Alvarado1, Octavio Ilizaliturri-Guerra1, Gisela Garcia-Arellano1, Andrea C Garza-Acosta4.   

Abstract

The objective was to compare the prevalence of subclinical atherosclerosis and cardiovascular risk (CVR) reclassification using six CVR algorithms and a carotid ultrasound in psoriatic arthritis (PsA) patients and controls. The method was cross-sectional study. A total of 81 patients aged 40-75 years, who fulfilled the 2006 CASPAR criteria and 81 controls matched by age, gender, and comorbidities were recruited. CVR was evaluated according to six CVR algorithms, including Framingham Risk Score (FRS)-lipids, FRS-body mass index (BMI), Atherosclerotic Cardiovascular Disease (ASCVD) Algorithm, Systematic Coronary Risk Evaluation (SCORE), QRISK3, and Reynolds Risk Score (RRS). A carotid ultrasound was performed to identify the presence of carotid plaque (CP) defined as a carotid intima media thickness ≥ 1.2 mm or a focal narrowing of the surrounding lumen ≥ 0.5mm. Patients with presence of CP, classified in the low-moderate risk by the CVR algorithms, were reclassified to a higher risk category. CP was more prevalent in PsA patients (44.4% vs 24.7%, p = 0.008), as was subclinical atherosclerosis (51.9% vs 33.3%, p = 0.017). When comparing the CVR reclassification to a higher risk category, a difference was found in the six CVR algorithms. The reclassification was more prevalent in PsA patients: 30.8% vs 12.3%, p = 0.004 with FRS-lipids; 28.4% vs 9.9%, p = 0.003 with FRS-BMI; 40.7% vs 19.8%, p = 0.003 with SCORE; 30.9% vs 16.0%, p = 0.026 with ASCVD algorithm; 37.0% vs 19.8%, p = 0.015 with RRS; and 33.3% vs 16.0%, p = 0.011 with QRISK3. The CVR algorithms underestimate the actual CVR of PsA patients. A carotid ultrasound should be considered as part of the CVR evaluation of PsA patients. KEY POINTS: • Subclinical atherosclerosis was more prevalent in psoriatic arthritis patients than controls. • Cardiovascular risk reclassification, through a carotid ultrasound, according to traditional cardiovascular risk algorithms was more common in psoriatic arthritis patients. • The cardiovascular risk algorithm that showed the lowest reclassification rate in psoriatic arthritis patients was the FRS-BMI. • All cardiovascular risk algorithms underestimate the actual risk of psoriatic arthritis patients, preventing the initiation of an adequate cardiovascular treatment.
© 2021. International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Atherosclerosis; Cardiovascular risk; Cardiovascular risk algorithms; Carotid ultrasound; Psoriatic arthritis

Mesh:

Substances:

Year:  2021        PMID: 34826020     DOI: 10.1007/s10067-021-06002-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  24 in total

1.  Defining remission and treatment success using the DAPSA score: response to letter by Helliwell and Coates.

Authors:  Monika M Schoels; Daniel Aletaha; Josef S Smolen
Journal:  Ann Rheum Dis       Date:  2015-10-22       Impact factor: 19.103

2.  Classification criteria for psoriatic arthritis: development of new criteria from a large international study.

Authors:  William Taylor; Dafna Gladman; Philip Helliwell; Antonio Marchesoni; Philip Mease; Herman Mielants
Journal:  Arthritis Rheum       Date:  2006-08

3.  Role of Carotid Ultrasound and Systematic Coronary Risk Evaluation Charts for the Cardiovascular Risk Stratification of Patients with Psoriatic Arthritis.

Authors:  María Paz Martínez-Vidal; Mariano Andrés; Vega Jovaní; Carlos Santos-Ramírez; Cintia Romera; Cristina Fernández-Carballido
Journal:  J Rheumatol       Date:  2019-06-15       Impact factor: 4.666

4.  The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease.

Authors:  Lihi Eder; Vinod Chandran; Dafna D Gladman
Journal:  Ann Rheum Dis       Date:  2013-07-25       Impact factor: 19.103

Review 5.  EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.

Authors:  R Agca; S C Heslinga; S Rollefstad; M Heslinga; I B McInnes; M J L Peters; T K Kvien; M Dougados; H Radner; F Atzeni; J Primdahl; A Södergren; S Wallberg Jonsson; J van Rompay; C Zabalan; T R Pedersen; L Jacobsson; K de Vlam; M A Gonzalez-Gay; A G Semb; G D Kitas; Y M Smulders; Z Szekanecz; N Sattar; D P M Symmons; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2016-10-03       Impact factor: 19.103

6.  Exploring cardiovascular disease risk evaluation in patients with inflammatory joint diseases.

Authors:  A G Semb; E Ikdahl; J Hisdal; I C Olsen; S Rollefstad
Journal:  Int J Cardiol       Date:  2016-08-07       Impact factor: 4.164

7.  Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis.

Authors:  Lihi Eder; Arane Thavaneswaran; Vinod Chandran; Richard Cook; Dafna D Gladman
Journal:  Ann Rheum Dis       Date:  2014-05-14       Impact factor: 19.103

8.  Comparison of statin eligibility according to the Adult Treatment Panel III, ACC/AHA blood cholesterol guideline, and presence of carotid plaque by ultrasound in Mexican mestizo patients with rheumatoid arthritis.

Authors:  Dionicio A Galarza-Delgado; Jose R Azpiri-Lopez; Iris J Colunga-Pedraza; Jesus A Cardenas-de la Garza; Raymundo Vera-Pineda; Judith I Garcia-Colunga; Rosa I Arvizu-Rivera; Adrian Martinez-Moreno; Jesus Z Villarreal-Perez; Guillermo Elizondo-Riojas; Mario A Garza Elizondo
Journal:  Clin Rheumatol       Date:  2016-05-25       Impact factor: 2.980

Review 9.  The pathogenesis of psoriatic arthritis.

Authors:  Douglas J Veale; Ursula Fearon
Journal:  Lancet       Date:  2018-06-01       Impact factor: 79.321

10.  The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: the multi-ethnic study of atherosclerosis.

Authors:  Joseph F Polak; Moyses Szklo; Richard A Kronmal; Gregory L Burke; Steven Shea; Anna E H Zavodni; Daniel H O'Leary
Journal:  J Am Heart Assoc       Date:  2013-04-08       Impact factor: 5.501

View more
  2 in total

1.  The comparison of cardiovascular disease risk prediction scores and evaluation of subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study.

Authors:  Hafis Muhammed; Durga Prasanna Misra; Neeraj Jain; Sujata Ganguly; Sarit Sekhar Pattanaik; Mohit K Rai; Anamika Kumari Anuja; Namita Mohindra; Sudeep Kumar; Vikas Agarwal
Journal:  Clin Rheumatol       Date:  2022-08-25       Impact factor: 3.650

2.  Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric Study.

Authors:  Yannick Degboé; Richard Koch; Laurent Zabraniecki; Bénédicte Jamard; Guillaume Couture; Jean Bernard Ruidavets; Jean Ferrieres; Adeline Ruyssen-Witrand; Arnaud Constantin
Journal:  Front Med (Lausanne)       Date:  2022-05-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.